94 results
8-K
EX-99.1
7lth7ttw r8j
10 Aug 23
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
4:09pm
424B5
o2tue
11 May 23
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
6jza2pvjtqdu53ce35
11 May 23
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
4:10pm
PRE 14A
0e9272tq60 vtyju
14 Apr 23
Preliminary proxy
6:03am
8-K
EX-99.1
5pttf2
30 Mar 23
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
4:09pm
8-K
EX-99.1
zapeh4w rwo3
10 Nov 22
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
4:14pm
8-K
EX-99.1
dmqwtouo37
11 Aug 22
Results of Operations and Financial Condition
4:10pm
8-K
gjvmts
6 Jul 22
Cost Associated with Exit or Disposal Activities
4:26pm